People Science, Inc.
13
2
8
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Impact of B. Adolescentis iVS-1 Probiotic on Gastrointestinal Outcomes
Role: collaborator
Consumer Health Study Aims to Evaluate the Safety, Tolerability and Impact of ED02 Probiotic Supplement on Gastrointestinal Outcomes
Role: collaborator
A Study to Evaluate the Impact of a Magnolia Officinalis Dietary Supplement on Immune Biomarkers in Subjects With Psoriasis
Role: collaborator
Immune Defense Protein Impact On Respiratory Immune Outcomes
Role: collaborator
A Consumer Health Study Evaluating the Impact of Pivit on Weight Loss and Appetite in Overweight Individuals
Role: collaborator
Observational Pilot Study to Explore the Social and Health Impacts of a New Model of Care in Oregon: Psilocybin Services on Alcoholism
Role: collaborator
Investigating the Tolerability of Oat Fiber (BG-OS) in Healthy Individuals
Role: collaborator
Observational Metabolic Health Study
Role: collaborator
Investigating the Effectiveness of 2 Different Doses of BIOHM FX Probiotic Blend in Improving Digestive Symptoms
Role: collaborator
Probiotics for Anxiety Study
Role: collaborator
Combined Effects of Prunus Cerasus and Apocynum Venetum On Sleep and Anxiety in Adults With Insomnia
Role: collaborator
A Direct-to-Consumer Study Investigating the Effect of Specific Cannabinoid Products on Motivation, Energy Level, Focus, and Appetite in Healthy Adults
Role: collaborator
A Study of the Next-generation Probiotic, Veillonella Atypica FB0054 vs Placebo
Role: collaborator
All 13 trials loaded